Despite indications that the global economy is continuing to slow, the outlook for sales growth within the instrument and lab product industry is positive. In late October, 15 industry executives completed the online IBO Business Climate Survey. The respondents were IBO subscribers and other solicited participants, each representing a unique company or business unit. The […]
Calendar year second quarter organic growth continued at a strong pace for major US publicly held instrument and laboratory product companies. However, currency headwinds, as well as weakness in industrial markets and Japan expunged organic growth. Currency reduced gains by about 7%, resulting in roughly flat second quarter average sales growth. Pharmaceutical and biotechnology markets […]
With the first half of the year behind us, let us reflect on the state of the analytical and life science instrumentation and lab products market, how it has developed thus far and what is in store for the rest of 2015. The original January forecast (see IBO 1/15/15) was published without the benefit of […]
The Japanese government will work with three biobanks to improve medical treatments for patients based on their genetic information. Beginning next year, the country’s budget will include funds for this initiative in genomic medicine. The Japan Agency for Medical Research and Development and the biobanks will standardize data formats of people’s genetic information. The biobanks […]
As part of its “Japan is Back” strategy for economic growth, the Japanese government plans to promote technological innovation by setting up a system of research universities to partner with start-up companies. The goal is to stimulate the generation of new companies from universities. The government also plans a system of graduate schools to collaborate […]
The fiscal 2016 budget for Japan was passed in April, totaling ¥96.34 trillion ($775 billion). At ¥3,447 billion, funding for science, technology and innovation declined 5.0%. The Ministry of Education, Culture, Sports, Science and Technology received ¥2,280 billion, down 1.4%. Much of the change reflects decreased subsidies for the country’s national universities. The Ministry of […]
Expectations for industry growth showed little change compared to last fall (see IBO 10/15/14), according to IBO’s biannual Business Climate Survey. However, compared to a year ago, sentiments were more restrained. This spring, 57% of survey participants expect instrument and laboratory product–industry sales to increase moderately. Forty-three percent expect them to stay the same. However, […]
As of this month, the Japan Agency for Medical Research and Development will have been established to improve medical care, and help develop drugs and medical equipment in the country. It will distribute the ¥140 billion ($1.16 billion) research budget of several ministries across nine fields that the Japanese government considers important. The areas are […]
R&D spending rose an estimated 4.7% in fiscal year 2014 (ending March 31, 2014), the first increase since FY12, according to the results of a survey by Japan’s Ministry of Internal Affairs and Communications (MIC) published in December 2015 and a report compiled by the NSF’s Tokyo office released this month. The MIC survey of […]
Pay Invoice
Latest Blogs
-
Paving The Way for Change: 10x Genomics Announces Corporate Strategies for a Fruitful 2025
February 26, 2025 1:05 pm
-
SLAS2025: Lab Automation and More
January 23, 2025 4:00 pm
-
LAUDA: Temperature Control Innovation
December 10, 2024 4:11 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
